Canopy Growth Corporation CGC Business Segments
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Cannabis | $213.94M+3.3% | $207.14M+3.4% | $200.34M+3.5% | $193.53M+3.6% | $186.73M-0.7% | |
| Storz And Bickel | $70.66M-3.7% | $73.4M-2.9% | $75.57M-2.2% | $77.3M-6.0% | $82.27M-12.2% | |
| Revenue (Gross) by Product | ||||||
| Canadian Adult Use Cannabis | $94.47M+0.2% | $94.29M+1.9% | $92.52M+6.4% | $86.97M+10.3% | $78.83M-0.7% | |
| Canadian Medical Cannabis | $90.82M+6.2% | $85.51M+3.6% | $82.58M+3.9% | $79.44M+3.1% | $77.03M+3.1% | |
| International Markets Cannabis | $28.65M+13.8% | $25.19M-9.9% | $27.95M-10.4% | $31.21M+1.1% | $30.87M+8.0% | |
| Storz Bickel | $70.66M-3.7% | $73.4M-2.9% | $75.57M-2.2% | $77.3M-6.0% | $82.27M-12.2% | |
| Revenue by Geography | ||||||
| CA | $186.09M+3.5% | $179.86M+2.7% | $175.15M+5.2% | $166.46M+6.8% | $155.91M+0.9% | |
| DE | $62.07M+5.7% | $58.75M+2.6% | $57.29M-2.5% | $58.77M-1.9% | $59.9M-6.9% | |
| US | $28.27M-4.1% | $29.49M-8.9% | $32.38M-2.9% | $33.35M-7.3% | $35.99M-10.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Canopy Growth Corporation break its business down?
- Canopy Growth Corporation (CGC) reports revenue by business across 2 parts — Cannabis and Storz And Bickel. Each is extracted from the segment footnotes and tracked over time.
- Where does Canopy Growth Corporation's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Canopy Growth Corporation's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
